Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

Share Price is delayed by 15 minutes
Get Live Data
150.00    3.20 (2.18%)
Bid:
150.00
Ask:
150.00
Spread: 0.00 (0.00%)
Market Cap: £250.75m
MCB Live PriceLast checked at - London Stock Exchange

Intraday Mcbride Share Chart

Trading Update

11 Jul 2019 07:00

RNS Number : 1595F
McBride PLC
11 July 2019
Β 
11 July 2019

Β 

McBride plc

Β 

Trading update

Β 

McBride plc (the "Group"), the leading European manufacturer and supplier of Contract Manufactured and Private Label products for the domestic Household and professional cleaning and hygiene markets, today provides a trading update for the twelve months ending 30 June 2019 and the current financial year.

Β 

Adjusted operating profit, adjusted PBT and adjusted EPS for the year ending 30 June 2019 are anticipated to be broadly in line with current market expectations.

Β 

Overall, underlying full year revenues from continuing operations at constant currency were 2.7% higher than the previous year.

Β 

Second half year trading, especially in the final quarter, was marginally weaker than expected. In Household (now including Asia), underlying second half growth at constant currency was 1.6% and full year growth ended at 3.7% year on year. Second half year revenues were 1.7% lower than the first half year, with the UK and France especially seeing weak sales activity. The East region continued to show good growth albeit at a lower rate than seen in the first half year.

Β 

Net Debt closed at circa Β£121m (30 June 2018: Β£114.3m). The Net Debt closing figure is higher than expected due to higher working capital, partly due to phasing, as well as a translation impact from weaker sterling.

Β 

The Group will announce its preliminary results for the year ended 30 June 2019 on 5 September 2019.

Β 

As the Group starts its new financial year, sales activity levels are weaker than expected. This is mostly due to slow demand levels across a number of markets in addition to the net effect of contract losses mostly attributable to the Group's pricing actions last year. As a result the Group now expects Household revenues to be flat for the 12 months to 30 June 2020 with Group earnings expected to be slightly below the year to 30 June 2019.

Β 

Directorate update

Β 

Further to the announcement of 2 May 2019, the Group advises that it has been agreed that Rik De Vos, CEO, will step down from the Board of McBride on 19 July 2019 and leave the Company on 31 August 2019.

Β 

The Board announces that Chris Smith, Chief Finance Officer, will act as Interim CEO from 22 July 2019 whilst the search for Rik's successor is completed and will revert to his current role once the new CEO is in place. During this interim period, David Rattigan, currently Group Financial Controller, will assume the role of Interim Director of Finance, responsible for the Group's finance function.

Β 

Β 

For further information please contact:

Β 

McBride plc

Rik De Vos, Chief Executive Officer

0161 203 7570

Chris Smith, Chief Finance Officer

0161 203 7570

FTI Consulting

020 3727 1017

Ed Bridges, Nick Hasell

Β 

Β 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation which came into effect on 3 July 2016.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
TSTBBLLFKDFZBBB
Date   Source Headline
16th Jun 20267:00 amRNSTransaction in Own Shares
15th Jun 20266:11 pmRNSDirector/PDMR Shareholding
12th Jun 20267:00 amRNSTrading and Acquisition Update
11th Jun 20261:44 pmRNSDirector/PDMR Shareholding
2nd Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSSecond tranche of share buyback programme
1st May 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSProposed Acquisition & Trading Conditions Update
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSDirector Appointment
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20266:28 pmRNSDirectorate change
27th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.